29 September 2020
1300 794 893
Subscribe

Claire Aitchison

Claire has over 13 years' experience as an analyst specialising in equities and managed investments. Claire is the Lead analyst with respect to small cap research mandates at Independent Investment Research. Previously, she was employed at Aegis Equities Research and joined IIR when that business was sold to Morningstar. She has a Bachelor of Commerce with Distinction and a Grad Diploma in Accounting from Deakin University.

11 September 2020
2 star performers in the biotech sector

We look at two stocks in the IIR Pharma & Biotech Index that were the best performers in the top 10, both increasing over 40% for the month on the back of promising developments for their respective products.

10 September 2020
5 of the best biotechs

Let’s look at CSL, Fisher & Paykel Healthcare, Cochlear, Resmed and Ansell.

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
1300 794 893
© 2006-2020 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
homephoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram